Silverberg Bernstein Capital Management LLC Neogenomics Inc Transaction History
Silverberg Bernstein Capital Management LLC
- $146 Billion
- Q2 2025
A detailed history of Silverberg Bernstein Capital Management LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Silverberg Bernstein Capital Management LLC holds 40,380 shares of NEO stock, worth $259,239. This represents 0.2% of its overall portfolio holdings.
Number of Shares
40,380
Previous 21,080
91.56%
Holding current value
$259,239
Previous $200 Million
47.55%
% of portfolio
0.2%
Previous 0.19%
Shares
5 transactions
Others Institutions Holding NEO
# of Institutions
284Shares Held
127MCall Options Held
942KPut Options Held
172K-
Black Rock Inc. New York, NY19.7MShares$126 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.3MShares$91.5 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.72MShares$43.1 Million0.04% of portfolio
-
First Light Asset Management, LLC Edina, MN6.04MShares$38.8 Million7.36% of portfolio
-
Janus Henderson Group PLC London, X05.74MShares$36.9 Million0.03% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $808M
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...